Table 2 |
|||||
|
Univariate analysis of potential factors associated with a diagnosis of definite TBM; definite TBM = 44; not definite TBM = 47 |
|||||
|
Factor |
(+) in definite TBM (n = 44) |
(-) in definite TBM (n = 44) |
Crude odds ratio |
95% C. I. |
P value |
|
|
|||||
|
New-onset seizure |
14 |
13 |
1·04 |
0·38-2·86 |
0·93 |
|
|
|||||
|
New-onset neurologic deficit |
24 |
21 |
0·45 |
1·19-2·93 |
0·76 |
|
|
|||||
|
Presence of PTB |
15 |
10 |
1·72 |
0·60-4·98 |
0·26 |
|
|
|||||
|
Lymphocytic pleocytosis |
32 |
18 |
3·56 |
1·32-9·74 |
0·005 |
|
|
|||||
|
Decreased glucose |
33 |
21 |
3·00 |
1·10-8·30 |
0·017 |
|
|
|||||
|
Increased protein |
40 |
30 |
4·89 |
1·12-24·43 |
0·015 |
|
|
|||||
|
Pasco BMC Research Notes 2012 5:49 doi:10.1186/1756-0500-5-49 |
|||||